Safety and efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid and CNS tumors: Results from a phase 1/2a study.

Authors :: De La Fuente, Macarena Ines
Rodon Ahnert, Jordi
Yaeger, Rona
Tsai, Frank Yung-Chin
Janku, Filip
Butowski, Nicholas A.
Allen, Carl E.
Ammakkanavar, Natraj Reddy
Taylor, Jennie Webster
Michelson, Glenn
Kline, Irina
Paz, Michael
Tussay-Lindenberg, Alexia
Wong, Kongming
Shepherd, Stacie Peacock
Jiang, Ping
Sherman, Eric Jeffrey
Source :: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p3006-3006, 1p
Publication Year :: 2023

Full Text Access

Tools